Cargando…

The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy

AIM: This study aimed to explore the role of the developed nomogram in the prognosis of esophageal squamous cell carcinoma (ESCC). METHODS: A total of 181 ESCC patients were randomly divided into a training cohort (n = 141) and a validation cohort (n = 40). Significant factors impacting overall surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ling, Lyu, Jiahua, Chen, Meihua, Wang, Liu, Huang, Jing, Wei, Yajun, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890129/
https://www.ncbi.nlm.nih.gov/pubmed/35251695
http://dx.doi.org/10.2144/fsoa-2021-0080
Descripción
Sumario:AIM: This study aimed to explore the role of the developed nomogram in the prognosis of esophageal squamous cell carcinoma (ESCC). METHODS: A total of 181 ESCC patients were randomly divided into a training cohort (n = 141) and a validation cohort (n = 40). Significant factors impacting overall survival (OS) were identified in the training set and integrated into the nomogram based on Cox proportional hazards regression. RESULTS: In the training cohort, the median OS in the high group (≥222) was 49.9 months and the median OS in the low group (<222) was 14.4 months. Multivariate analysis revealed that age, Karnofsky performance status score, tumor stage, chemotherapy, BMI, cervical esophageal carcinoma index and neutrophil to lymphocyte ratio were predictors of OS. CONCLUSION: The developed nomogram can effectively predict the survival prognosis of ESCC patients.